A Study of MT-0551 in Patients With Systemic Sclerosis
Clinical trial NCT05198557 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05198557
- Sponsor
- Tanabe Pharma Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-20
- Primary completion
- 2025-07-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.